These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 29871823)

  • 1. Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton.
    Steinmetz MO; Prota AE
    Trends Cell Biol; 2018 Oct; 28(10):776-792. PubMed ID: 29871823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products as antimitotic agents.
    Dall'Acqua S
    Curr Top Med Chem; 2014; 14(20):2272-85. PubMed ID: 25434355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimitotic agents].
    Fukuoka K; Saijo N
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1519-25. PubMed ID: 9309150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pyranoxanthone as a Potent Antimitotic and Sensitizer of Cancer Cells to Low Doses of Paclitaxel.
    França F; Silva PMA; Soares JX; Henriques AC; Loureiro DRP; Azevedo CMG; Afonso CMM; Bousbaa H
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zerumbone, a cyclic sesquiterpene, exerts antimitotic activity in HeLa cells through tubulin binding and exhibits synergistic activity with vinblastine and paclitaxel.
    Ashraf SM; Sebastian J; Rathinasamy K
    Cell Prolif; 2019 Mar; 52(2):e12558. PubMed ID: 30525278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in discovery and development of antimitotic agents.
    Kiselyov A; Balakin KV; Tkachenko SE; Savchuk N; Ivachtchenko AV
    Anticancer Agents Med Chem; 2007 Mar; 7(2):189-208. PubMed ID: 17348827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stathmin potentiates vinflunine and inhibits Paclitaxel activity.
    Malesinski S; Tsvetkov PO; Kruczynski A; Peyrot V; Devred F
    PLoS One; 2015; 10(6):e0128704. PubMed ID: 26030092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies.
    Magnani M; Ortuso F; Soro S; Alcaro S; Tramontano A; Botta M
    FEBS J; 2006 Jul; 273(14):3301-10. PubMed ID: 16803461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
    Derry WB; Wilson L; Jordan MA
    Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloids.
    Coderch C; Morreale A; Gago F
    Anticancer Agents Med Chem; 2012 Mar; 12(3):219-25. PubMed ID: 22044006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitosis is not a key target of microtubule agents in patient tumors.
    Komlodi-Pasztor E; Sackett D; Wilkerson J; Fojo T
    Nat Rev Clin Oncol; 2011 Feb; 8(4):244-50. PubMed ID: 21283127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubule-Targeting Drugs: More than Antimitotics.
    Kaul R; Risinger AL; Mooberry SL
    J Nat Prod; 2019 Mar; 82(3):680-685. PubMed ID: 30835122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viriditoxin Stabilizes Microtubule Polymers in SK-OV-3 Cells and Exhibits Antimitotic and Antimetastatic Potential.
    Su M; Zhao C; Li D; Cao J; Ju Z; Kim E; Jung YS; Jung JH
    Mar Drugs; 2020 Aug; 18(9):. PubMed ID: 32867174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell Death.
    Borowiak M; Nahaboo W; Reynders M; Nekolla K; Jalinot P; Hasserodt J; Rehberg M; Delattre M; Zahler S; Vollmar A; Trauner D; Thorn-Seshold O
    Cell; 2015 Jul; 162(2):403-411. PubMed ID: 26165941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosis.
    Jordan MA; Ojima I; Rosas F; Distefano M; Wilson L; Scambia G; Ferlini C
    Chem Biol; 2002 Jan; 9(1):93-101. PubMed ID: 11841942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
    Kamath K; Jordan MA
    Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubules in apoptosis induction: are they necessary?
    Estève MA; Carré M; Braguer D
    Curr Cancer Drug Targets; 2007 Dec; 7(8):713-29. PubMed ID: 18220532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target driven preclinical screening for new antimitotic chemotherapy agents.
    Novío S; Freire-Garabal M; Núñez MJ
    Curr Top Med Chem; 2014; 14(20):2263-71. PubMed ID: 25434356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of antitumor drugs that interact with microtubules and tubulin.
    Jordan MA
    Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):1-17. PubMed ID: 12678749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms.
    Wang Y; Yin S; Blade K; Cooper G; Menick DR; Cabral F
    Biochemistry; 2006 Jan; 45(1):185-94. PubMed ID: 16388594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.